R. Brouard

1.1k total citations
31 papers, 840 citations indexed

About

R. Brouard is a scholar working on Pulmonary and Respiratory Medicine, Social Psychology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R. Brouard has authored 31 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Social Psychology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R. Brouard's work include Neuroendocrine regulation and behavior (8 papers), Electrolyte and hormonal disorders (8 papers) and Menstrual Health and Disorders (3 papers). R. Brouard is often cited by papers focused on Neuroendocrine regulation and behavior (8 papers), Electrolyte and hormonal disorders (8 papers) and Menstrual Health and Disorders (3 papers). R. Brouard collaborates with scholars based in France, United States and Sweden. R. Brouard's co-authors include Thomas Bossmar, Mats Åkerlund, Jan Van Schoor, Margareta Steinwall, G.F. Joos, Michèle Lonergan, Ali Salahpour, André Laperrière, Jean-Pierre Morello and Virginie Bernier and has published in prestigious journals such as Hypertension, Journal of the American Society of Nephrology and European Respiratory Journal.

In The Last Decade

R. Brouard

30 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Brouard France 15 269 248 246 161 112 31 840
Andersson Ke Sweden 20 147 0.5× 117 0.5× 68 0.3× 76 0.5× 152 1.4× 48 1.1k
Richard C. Vari United States 18 245 0.9× 177 0.7× 46 0.2× 412 2.6× 96 0.9× 50 1.0k
Mark K. Santillan United States 23 169 0.6× 130 0.5× 77 0.3× 120 0.7× 126 1.1× 114 1.5k
Kyra Whitmer United States 17 226 0.8× 239 1.0× 23 0.1× 120 0.7× 67 0.6× 29 1.2k
S Gepi-Attee United Kingdom 6 293 1.1× 87 0.4× 47 0.2× 105 0.7× 161 1.4× 14 1.5k
H Steinberg United States 11 113 0.4× 103 0.4× 95 0.4× 37 0.2× 84 0.8× 26 652
W.A.W. Walters Australia 13 117 0.4× 110 0.4× 36 0.1× 180 1.1× 62 0.6× 33 719
Malini Iyengar United States 18 86 0.3× 95 0.4× 55 0.2× 212 1.3× 28 0.3× 26 1.6k
Kathleen H. Wilson United States 17 103 0.4× 161 0.6× 41 0.2× 158 1.0× 53 0.5× 55 857
Louis L. Cregler United States 8 95 0.4× 84 0.3× 19 0.1× 239 1.5× 48 0.4× 19 1.0k

Countries citing papers authored by R. Brouard

Since Specialization
Citations

This map shows the geographic impact of R. Brouard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Brouard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Brouard more than expected).

Fields of papers citing papers by R. Brouard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Brouard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Brouard. The network helps show where R. Brouard may publish in the future.

Co-authorship network of co-authors of R. Brouard

This figure shows the co-authorship network connecting the top 25 collaborators of R. Brouard. A scholar is included among the top collaborators of R. Brouard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Brouard. R. Brouard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Brouard, R., M Wybier, Anne Miquel, & Jean‐Denis Laredo. (2006). The lucent rim: a radiographic and computed tomography sign of Paget's disease of the skull. European Radiology. 16(6). 1308–1311. 3 indexed citations
3.
Steinwall, Margareta, Thomas Bossmar, R. Brouard, et al.. (2005). The effect of relcovaptan (SR 49059), an orally active vasopressin V1areceptor antagonist, on uterine contractions in preterm labor. Gynecological Endocrinology. 20(2). 104–109. 30 indexed citations
4.
Bernier, Virginie, Jean-Pierre Morello, Ali Salahpour, et al.. (2005). Pharmacologic Chaperones as a Potential Treatment for X-Linked Nephrogenic Diabetes Insipidus. Journal of the American Society of Nephrology. 17(1). 232–243. 171 indexed citations
5.
Hayoz, Daniel, B Noël, Michèle Depairon, et al.. (2000). Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenon. Lara D. Veeken. 39(10). 1132–1138. 20 indexed citations
6.
Brouard, R., et al.. (2000). Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea. BJOG An International Journal of Obstetrics & Gynaecology. 107(5). 614–619. 50 indexed citations
7.
Åkerlund, Mats, Thomas Bossmar, R. Brouard, et al.. (1999). Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women. BJOG An International Journal of Obstetrics & Gynaecology. 106(10). 1047–1053. 104 indexed citations
8.
Deray, Gilbert, et al.. (1998). Clopidogrel Activities in Patients with Renal Function Impairment. Clinical Drug Investigation. 16(4). 319–328. 37 indexed citations
9.
Schmitt, Fernando, Flavio Martı́nez, G Brillet, et al.. (1998). Acute Renal Effects of AT1-Receptor Blockade After Exogenous Angiotensin II Infusion in Healthy Subjects. Journal of Cardiovascular Pharmacology. 31(2). 314–321. 19 indexed citations
10.
Åkerlund, Mats, Thomas Bossmar, R. Brouard, & Margareta Steinwall. (1998). Evidence for an Involvement of Vasopressin in Mechanism of Primary Dysmenorrhea and Effect of the Non-Peptide Vasopressin V1a Receptor Antagonist, SR 49059, on the Uterus of Non-Pregnant Women. Advances in experimental medicine and biology. 449. 467–472. 3 indexed citations
11.
Schoor, Jan Van, et al.. (1998). The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics. European Respiratory Journal. 12(1). 17–23. 83 indexed citations
12.
Brouard, R., et al.. (1998). Safety, Tolerability, and Pharmacokinetics of SR 49059, a V1A Vasopressin Receptor Antagonist, After Repeated Oral Administration in Healthy Volunteers. Advances in experimental medicine and biology. 449. 455–465. 18 indexed citations
13.
Boissonnat, P., M. de Lorgeril, Patricia Salen, et al.. (1997). A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients. European Journal of Clinical Pharmacology. 53(1). 39–45. 12 indexed citations
14.
Newton, John F., et al.. (1997). Determination of SR 49059 in human plasma and urine by LC-APCI/MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 15(12). 1913–1922. 7 indexed citations
15.
Bossmar, Thomas, et al.. (1997). Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin‐induced uterine contractions. BJOG An International Journal of Obstetrics & Gynaecology. 104(4). 471–477. 22 indexed citations
16.
McIntyre, Martin, et al.. (1996). Dose-Ranging Study of the Angiotensin II Receptor Antagonist Irbesartan (SR 47436/BMS-186295) on Blood Pressure and Neurohormonal Effects in Salt-Deplete Men. Journal of Cardiovascular Pharmacology. 28(1). 101–106. 27 indexed citations
17.
Berlin, Ivan, Gilbert Deray, P Lechat, et al.. (1993). Tertatolol Potentiates Exercise-Induced Atrial Natriuretic Peptide Release by Increasing Atrial Diameter in Healthy Subjects. Cardiology. 83(1). 16–24. 2 indexed citations
18.
Hannedouche, Thierry, R. Brouard, M. Godin, et al.. (1991). Chronic Effects of Tertatolol on Renal Function in Hypertensive Patients with Mild Chronic Renal Failure. Nephrology Dialysis Transplantation. 6(4). 252–256. 2 indexed citations
19.
Merdjan, Henri, et al.. (1990). Tianeptine and its main metabolite. Disposition in chronic renal failure and haemodialysis. Fundamental and Clinical Pharmacology. 4(6). 663–671. 8 indexed citations
20.
Brouard, R., et al.. (1989). Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis. Clinical Pharmacology & Therapeutics. 45(6). 674–681. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andersson Ke Breakdown of academic impact, for papers by Richard C. Vari Breakdown of academic impact, for papers by Mark K. Santillan Breakdown of academic impact, for papers by Kyra Whitmer Breakdown of academic impact, for papers by S Gepi-Attee Breakdown of academic impact, for papers by H Steinberg Breakdown of academic impact, for papers by W.A.W. Walters Breakdown of academic impact, for papers by Malini Iyengar Breakdown of academic impact, for papers by Kathleen H. Wilson Breakdown of academic impact, for papers by Louis L. Cregler
Rankless by CCL
2026